CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Fed up with brands that use corn syrup and skim milk, this mother developed her own ‘clean’ baby formula

From TechCrunch

By Lauren Forristal

July 29, 2025

Fed up with brands that use corn syrup and skim milk, this mother developed her own ‘clean’ baby formula

Fed up with brands that use corn syrup and skim milk, this mother developed her own ‘clean’ baby formula

When Esther Hallam welcomed her daughter, Nara, into the world, she faced the challenge of searching for trustworthy brands that offered high-quality organic infant formula in the U.S. 

Despite being available for nearly 160 years, the quality of infant formula options in the U.S. is still lacking, she believes. Many manufacturers opt for skim milk to cut costs, which allows them to add oils to meet nutritional requirements. Several formulas contain palm oil, soy, and corn syrup, which aren’t recommended for infants due to their potential health risks.

For instance, research has linked corn syrup to an increased risk of obesity, while palm oil has been shown to decrease calcium and fat absorptio .

“I became fixated by the fact that there wasn’t a good, organic infant formula that I trusted, that I wanted to feed my daughter in the United States, which is a first-world country,” Hallam told TechCrunch. 

For the past seven years, Hallam has been developing her own organic, whole-milk infant formula from scratch, with the help of scientists and pediatric nutritionists. 

Today marks the official launch of Nara Organics, which meets both European and U.S. safety standards, and is FDA-registered and USDA-certified. Most importantly, the formula is free from palm oil, soy, corn syrup, maltodextrin, and genetically modified organisms (GMOs), providing a clean option for conscientious parents looking to nourish their babies with the best possible ingredients.

Nara Organics claims to have the highest percentage of milk fat of any formula sold in the U.S. It also has the lowest percentage of plant-based oils, as the use of whole milk means that less oil is needed to achieve the correct fat content. The ingredient list on the package includes an “organic vegetable oil blend” made up of organic sunflower, coconut, and rapeseed oils, which provide essential fatty acids that support healthy development.

Image Credits:Nara Organics

While there are several brands with organic formulas, such as Bobbie and ByHeart, these products are manufactured in the U.S.

In contrast, Nara Organics chose not to produce its formula in American facilities, potentially due to previous issues with Cronobacter contamination, a germ that can survive in dry foods. In recent years, there have been several recalls of baby formula linked to outbreaks of Cronobacter.

This is why the company prefers to manufacture its formula in Germany, which just so happens to be the birthplace of powdered infant formula. 

Chief marketing officer Meika Hollender explained to TechCrunch that the company’s manufacturing partner utilizes technology “that doesn’t exist anywhere else in the world.”

“A critical piece of infant formula, in terms of its shelf life, is how much oxygen gets into the can while you’re sealing it. So if you go to facilities in the U.S., they’re open. When you’re filling, canning, and sealing the can, they’re just sort of out in the open air of the facility. And at our facility, the cans actually go into this chamber that has no oxygen in them,” Hollender said.

Nara has secured a total of $32 million from AlleyCorp, BBG Ventures, Corazon Ventures, Gingerbread Capital, and Torch Capital. Additionally, the company has attracted attention from high-profile celebrity investors, including tennis superstar Serena Williams, “Jane the Virgin” actress Gina Rodriguez, and the creators of “Nobody Wants This,” Erin and Sara Foster, among others. 

Nicky Hilton, fashion designer and philanthropist, is also an investor and advisor.   

“I breastfed all of my three children, but they also all had formula,” Hilton told us. “Every baby and parent is different, and not all mothers are able to breastfeed due to medical, physical, or personal reasons. I think there’s so much judgment and unnecessary pressure about breastfeeding… It’s really exciting to be a part of an innovative brand that is disrupting the baby formula market.”

With this support, Nara Organics could position itself as a key player in the organic formula market, which was valued at approximately $20.7 billio in 2023 and is expected to reach $37 billion by 2032.

Image Credits:Nara Organics

The formula is now available for purchase on the company’s website. Customers can choose the starter bundle for $36, which includes two cans. Alternatively, they can sign up for a subscription that delivers either four or six cans every four weeks, priced at $136 or $243, respectively. Each can makes about 25 four-ounce bottles.

It also can be purchased through the company’s free mobile app, which Hallam launched in 2018. The app is designed to assist users in tracking essential aspects of infant care, including monitoring baby feeding times, keeping a log of wet and soiled diapers, and tracking tummy time exercises.

As part of its launch, the company is donating over 1,400 cans of infant formula to the Good+Foundatio , a nonprofit organization working to end multi-generational poverty by supplying essential items and services to under-resourced parents and caregivers.

View original article on techcrunch.com

Most Recent

Amazon is taking its biggest shot at Nvidia yet with new TorchNeuron dev tool

Amazon wants to break Nvidia’s hold on PyTorch, the free toolkit used to build most AI apps, so that more developers run their apps on alternative chips like its own.

Oct 19, 2026

Replika’s founder built the AI assistant she pitched at Disrupt 12 years ago

Eugenia Kuyda's newest startup Wabi is positioned to take advantage of an idea she had more than a decade ago. Wabi offers a personal AI assistant with a twist, free and downloadable to anyone today.

Oct 19, 2026

AI assistant startup Town nabs unicorn valuation 4 months after launch

AI assistant startup Town nabbed a unicorn valuation on Monday, announcing a $108 million Series B round co-led by Forerunner Ventures and Menlo Ventures.

Oct 19, 2026

Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics

Even Healthcare reaches a $300 million valuation in a Khosla Ventures-led round as it plans to expand its hospital network in India.

Oct 19, 2026

Similar Posts

Infant formula company Bobbie takes in $70M to acquire Nature’s One

With the Nature’s One acquisition, Bobbie becomes the third-largest fully integrated brand in the U.S. and will grow to a 15% non-WIC market share.

Jul 12, 2023

Fed up with brands that use corn syrup and skim milk, this mother developed her own ‘clean’ baby formula

Nara Organics is a new organic, whole milk baby formula brand that's free from palm oil, soy, corn syrup, maltodextrin, and GMOs.

Jul 29, 2025

BBy device turns breast milk into powder, helps NICU nurses avoid lengthy ‘milk shift’

The breast milk powder retains its nutrition and immunological properties and is shelf-stable for up to six months.

May 25, 2023

Portuguese Biotech Startup Bags 5M to Bring Infant Formula Nutritionally Closer to Breast Milk

Portuguese startup CarboCode, which is producing human-identical breast milk molecules via biocatalysis and fermentation, has raised 5M from investors.

Jan 13, 2025